 |
WUSM OB Insulin |
|---|
| このアプリは現在ストアで閲覧することができません。 | ||||
|
価格 | 無料 | ダウンロード |
|
|---|---|---|---|---|
| ｼﾞｬﾝﾙ | メディカル | |||
サイズ | 1.1MB | |||
| 開発者 | Washington University in St. Louis | |||
| 順位 |
| |||
| ﾘﾘｰｽ日 | 2014-04-16 10:56:20 | 評価 | 評価が取得できませんでした。 | |
| 互換性 | iOS 8.0以降が必要です。 iPhone、iPad および iPod touch 対応。 | |||
|
||||
A quick and easy calculator to determine a starting dose for a pregnant woman requiring insulin. Using known protocols, users input maternal weight and the trimester to calculate the dose of both long and short acting insulins. Users can even select between regular insulin and faster acting medications.
Copyright:
2014 - Muhammad Alsharif and Washington University in St. Louis. All Rights Reserved.
The Developer:
Mr. Muhammad H. Alsharif is a graduate student at the Computer Science and Engineering department of Washington University in St.Louis. (mhalsharif@gmail.com)
Medical Contributors:
Dr. Anthony Shanks, MD, Assistant Professor, Maternal Fetal Medicine (shanksa@wudosis.wustl.edu)
Dr. Kenan Omurtag, MD, Assistant Professor, Reproductive Endocrinology and Infertility (omurtagk@wudosis.wustl.edu)
Permission Statement:
The developer grants permission to use and reproduce the OBInsulin exactly as it appears here without modification or editing of any kind solely for end user use in clinical care or research in clinical care or research (the “Purpose”). For the avoidance of doubt, the Purpose does not include the (i) sale, distribution or transfer of the OBInsulin or copies thereof for any consideration or commercial value; (ii) the creation of any derivative works, including translations; and/or (iii) use of the OBInsulin as a marketing tool for the sale of any drug.
DISCLAIMER:
THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS \AS IS\ AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE SOFTWARE WILL NOT INFRINGE ANY PATENT COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.
Medical References:
Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003;102:857068.
Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestation diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988;159:616-21.
ACOG Practice Bulletin. Gestational Diabetes. Number 137, August 2013.
更新履歴
This app has been updated by Apple to display the Apple Watch app icon.
Minor bug fixes
Copyright:
2014 - Muhammad Alsharif and Washington University in St. Louis. All Rights Reserved.
The Developer:
Mr. Muhammad H. Alsharif is a graduate student at the Computer Science and Engineering department of Washington University in St.Louis. (mhalsharif@gmail.com)
Medical Contributors:
Dr. Anthony Shanks, MD, Assistant Professor, Maternal Fetal Medicine (shanksa@wudosis.wustl.edu)
Dr. Kenan Omurtag, MD, Assistant Professor, Reproductive Endocrinology and Infertility (omurtagk@wudosis.wustl.edu)
Permission Statement:
The developer grants permission to use and reproduce the OBInsulin exactly as it appears here without modification or editing of any kind solely for end user use in clinical care or research in clinical care or research (the “Purpose”). For the avoidance of doubt, the Purpose does not include the (i) sale, distribution or transfer of the OBInsulin or copies thereof for any consideration or commercial value; (ii) the creation of any derivative works, including translations; and/or (iii) use of the OBInsulin as a marketing tool for the sale of any drug.
DISCLAIMER:
THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS \AS IS\ AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE SOFTWARE WILL NOT INFRINGE ANY PATENT COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.
Medical References:
Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003;102:857068.
Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R. Pregestation diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988;159:616-21.
ACOG Practice Bulletin. Gestational Diabetes. Number 137, August 2013.
更新履歴
This app has been updated by Apple to display the Apple Watch app icon.
Minor bug fixes
ブログパーツ第二弾を公開しました！ホームページでアプリの順位・価格・周辺ランキングをご紹介頂けます。
ブログパーツ第2弾！
アプリの周辺ランキングを表示するブログパーツです。価格・順位共に自動で最新情報に更新されるのでアプリの状態チェックにも最適です。
ランキング圏外の場合でも周辺ランキングの代わりに説明文を表示にするので安心です。
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。ただし、一般公開されているページでご使用頂かないと表示されませんのでご注意ください。
幅200px版
幅320px版
お気に入りのアプリをご紹介頂くためのブログパーツです。アプリの価格や順位表示は毎日自動更新♪
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。
※配信を停止させていただく可能性もございますので、タグの改変はご遠慮ください。
Now Loading...
「iPhone & iPad アプリランキング」は、最新かつ詳細なアプリ情報をご紹介しているサイトです。
お探しのアプリに出会えるように様々な切り口でページをご用意しております。
「メニュー」よりぜひアプリ探しにお役立て下さい。
Presents by $$308413110 スマホからのアクセスにはQRコードをご活用ください。 →
Now loading...